investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Genetic Susceptibility and Risk Model for Pancreatic Cancer
Peng Wei
2 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Steven Gallinger
Toronto General Hospital
Toronto, Canada
University Health Network
Toronto, Canada
Mount Sinai Hospital
Toronto, Canada
Carlo La Vecchia
Mario Negri Institute for Pharmacological Research (IRCCS)
Milan, Italy
Peng Wei
University of Texas Health Science Center at Houston
Houston, United States
Related projects
Mark R Philips
Characterization of lcmt in Animal Models of Cancer
Pancreas
Pathology
S Perwez Hussain
Role of Immune and Inflammation Mediators in Progression of Pancreatic Cancer
Pancreas
Pathology
Jacob Houghton
Developing an Anti-sialyl-Lewisa Diabody for ImmunoPET Imaging of Pancreas Cancer
Pancreas
Pathology
Robert M Straubinger
Tumor priming sequences combined with novel nanoparticle drug carriers for enhanced therapeutic efficacy in pancreatic cancer: a tripartite USA/Northern Ireland/Republic of Ireland consortium
Pancreas
Pathology
Gwen Lomberk
Novel Experimental Therapeutics for Pancreatic Cancer
Pancreas
Pathology
Channing J Der
Identification of synthetic lethal interactors in pancreatic cancer
Pancreas
Pathology
Udo Rudloff
Preclinical Drug Development in Pancreatic Cancer
Pancreas
Pathology
Eric Collisson
Crucial Microenvironmental Cofactors for Pancreatic Cancer Pathogenesis
Pancreas
Pathology
Philip D Greenberg
Mechanisms of Murine Turmor Eradication by Immunotherapy
Pancreas
Pathology
